SCHEMBL19419941

SCHEMBL19419941

Cc1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 11/20 0.77
MEN1 O00255 10/20 0.77
MAPT P10636 10/20 0.77
RECQL P46063 5/20 0.77
RAB9A P51151 5/20 0.77
THRB P10828 4/20 0.77
MAPK1 P28482 3/20 0.77
NPC1 O15118 3/20 0.77
GPR35 Q9HC97 1/20 0.73
ALDH1A1 P00352 5/20 0.57
POLB P06746 3/20 0.57
HPGD P15428 1/20 0.57
ALOX12 P18054 1/20 0.57
LMNA P02545 1/20 0.55
DUSP22 Q9NRW4 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
PKM P14618 2/20 0.46
PSMD14 O00487 1/20 0.46
ALPG P10696 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14680223 0.87 MEN1 (1.00) KMT2AMEN1MAPTRECQLRAB9A
SCHEMBL15761667 0.75 HSPD1 (0.71) KMT2AMEN1MAPTRAB9AMAPK1
SCHEMBL13873081 0.73 KMT2A (0.50) KMT2AMEN1MAPTRECQLRAB9A
SCHEMBL6282463 0.73 KMT2A (1.00) KMT2AMEN1MAPTRECQLRAB9A
SCHEMBL3895249 0.73 KMT2A (1.00) KMT2AMEN1MAPTRECQLRAB9A
SCHEMBL3895245 0.73 KMT2A (1.00) KMT2AMEN1MAPTRECQLRAB9A
SCHEMBL12637255 0.72 DUSP22 (0.65) KMT2AMEN1MAPTRAB9AMAPK1
SCHEMBL12637129 0.72 DUSP22 (0.80) KMT2AMEN1MAPTALDH1A1POLB
SCHEMBL12637123 0.71 CFTR (0.74) KMT2AMEN1MAPTRAB9AALDH1A1
SCHEMBL11595445 0.70 KMT2A (0.56) KMT2AMEN1MAPTRAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES TP53, NQO1, SHMT2 KMT2A 3471/4885MEN1 3416/4885MAPT 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.